[1] Rundshagen I.Postoperative cognitive dysfunction[J]. Dtsch Arztebl Int. 2014; 111(8):119-125. [2] Andersen JV, Schousboe A, Verkhratsky A.Astrocyte energy and neurotransmitter metabolism in Alzheimer’s disease: Integration of the glutamate/GABA-glutamine cycle[J]. Prog Neurobiol. 2022; 217:102331. [3] Henning A.Proton and multinuclear magnetic resonance spectroscopy in the human brain at ultra-high field strength: A review[J]. Neuroimage. 2018; 168:181-198. [4] Tumati S, Martens S, Aleman A.Magnetic resonance spectroscopy in mild cognitive impairment: systematic review and meta-analysis[J]. Neurosci Biobehav Rev. 2013; 37(10 Pt 2):2571-2586. [5] Fujima N, Carlota Andreu-Arasa V, Barest GD, et al. Magnetic Resonance Spectroscopy of the Head and Neck: Principles, Applications, and Challenges[J]. Neuroimaging Clin N Am. 2020; 30(3):283-293. [6] García-Figueiras R, Baleato-González S, Padhani AR, et al.Proton magnetic resonance spectroscopy in oncology: the fingerprints of cancer[J]? Diagn Interv Radiol. 2016; 22(1):75-89. [7] Rhodes CJ.Magnetic resonance spectroscopy[J]. Sci Prog. 2017; 100(3):241-292. [8] Haga KK, Khor YP, Farrall A, et al.A systematic review of brain metabolite changes, measured with 1H magnetic resonance spectroscopy, in healthy aging. Neurobiol Aging[J]. 2009; 30(3):353-363. [9] Hellström J, Romanos Zapata R, Libard S, et al.The value of magnetic resonance spectroscopy as a supplement to MRI of the brain in a clinical setting[J]. PLoS One. 2018; 13(11):e0207336. [10] Soares DP, Law M. Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications[J]. Clin Radiol.2009 Jan; 64(1):12-21. [11] Bertholdo D, Watcharakorn A, Castillo M.Brain proton magnetic resonance spectroscopy: introduction and overview[J]. Neuroimaging Clin N Am. 2013; 23(3):359-380. [12] Bolan PJ.Magnetic resonance spectroscopy of the breast: current status[J]. Magn Reson Imaging Clin N Am. 2013; 21(3):625-639. [13] Chabert J, Allauze E, Pereira B, et al.Glutamatergic and N-Acetylaspartate Metabolites in Bipolar Disorder: A Systematic Review and Meta-Analysis of Proton Magnetic Resonance Spectroscopy Studies[J]. Int J Mol Sci. 2022; 23(16):8974. [14] La PL, Joyce JM, Bell TK, et al.Brain metabolites measured with magnetic resonance spectroscopy in pediatric concussion and orthopedic injury: An Advancing Concussion Assessment in Pediatrics (A-CAP) study[J]. Hum Brain Mapp. 2023; 44(6):2493-2508. [15] Veeramuthu V, Seow P, Narayanan V, et al.Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI): An In Vivo Proton Magnetic Resonance Spectroscopy (1H-MRS) Study[J]. Acad Radiol. 2018; 25(9):1167-1177. [16] Guo Z, Liu X, Hou H, et al.(1)H-MRS asymmetry changes in the anterior and posterior cingulate gyrus in patients with mild cognitive impairment and mild Alzheimer’s disease[J]. Compr Psychiatry. 2016; 69:179-85. [17] Rodríguez-Nieto G, Levin O, Hermans L, et al.Organization of neurochemical interactions in young and older brains as revealed with a network approach: Evidence from proton magnetic resonance spectroscopy (1H-MRS)[J]. Neuroimage. 2023; 266:119830. [18] Rietzler A, Steiger R, Mangesius S, et al.Energy metabolism measured by 31P magnetic resonance spectroscopy in the healthy human brain[J]. J Neuroradiol. 2022; 49(5):370-379. [19] Meyerhoff DJ.Brain proton magnetic resonance spectroscopy of alcohol use disorders[J]. Handb Clin Neurol. 2014; 125:313-337. [20] Bittšanský M, Výbohová D, Dobrota D.Proton magnetic resonance spectroscopy and its diagnostically important metabolites in the brain[J]. Gen Physiol Biophys. 2012; 31(1):101-112. [21] Lin X, Chen Y, Zhang P, et al.The potential mechanism of postoperative cognitive dysfunction in older people[J]. Exp Gerontol. 2020; 130:110791. [22] Andersen JV, Christensen SK, Westi EW, et al.Deficient astrocyte metabolism impairs glutamine synthesis and neurotransmitter homeostasis in a mouse model of Alzheimer’s disease[J]. Neurobiol Dis. 2021; 148:105198. [23] McCarthy L, Verma G, Hangel G, et al. Application of 7T MRS to High-Grade Gliomas[J]. AJNR Am J Neuroradiol. 2022; 43(10):1378-1395. [24] Nummela AJ, Laaksonen LT, Laitio TT, et al.Effects of dexmedetomidine, propofol, sevoflurane and S-ketamine on the human metabolome: A randomised trial using nuclear magnetic resonance spectroscopy[J]. Eur J Anaesthesiol. 2022; 39(6):521-532. [25] Boretius S, Tammer R, Michaelis T, et al.Halogenated volatile anesthetics alter brain metabolism as revealed by proton magnetic resonance spectroscopy of mice in vivo[J]. Neuroimage. 2013; 69:244-255. [26] Söbbeler FJ, Carrera I, Pasloske K, et al.Effects of isoflurane, sevoflurane, propofol and alfaxalone on brain metabolism in dogs assessed by proton magnetic resonance spectroscopy (1H MRS)[J]. BMC Vet Res. 2018; 14(1):69. |